Mickaël Hiligsmann (M.J.C.)

Li, N., Majoie, M., Evers, S., Rijkers, K., Gubler, F., Rouhl, R., Lazeron, R., Klarenbeek, P., Laskier-Owens, V., & Hiligsmann, M. (2025). Budget impact analysis of cenobamate for epilepsy patients with drug-resistant focal onset seizures in the Netherlands. Journal of Medical Economics, 28(1), 114-123. https://doi.org/10.1080/13696998.2024.2443338

Vu, M. N., Westra, T. A., & Hiligsmann, M. (2025). A qualitative study on vaccination program accessibility for the elderly and medical risk groups in the south of the Netherlands. Vaccine: X, 27, Article 100713. https://doi.org/10.1016/j.jvacx.2025.100713

Fuggle, N. R., Chapurlat, R., Laslop, A., Al-Daghri, N., Alokail, M., Thiyagarajan, J. A., Balkowiec-Iskra, E., Berenbaum, F., Bemden, A. B., Borg, J.-J., Bruyere, O., Burlet, N., Cavalier, E., Rosa, M. M., Conaghan, P. G., Cooper, C., Dennison, E. M., Englund, M., Im, G., ... Harvey, N. C. (2025). Novel approaches to the stratified management of knee osteoarthritis. Nature Reviews Rheumatology, 21(11), 684-695. https://doi.org/10.1038/s41584-025-01305-x

Reising, R. C., El Alili, M., Kimman, M. L., & Hiligsmann, M. (2025). Integrating Environmental Aspects into Health Technology Assessment: A Qualitative Study among Dutch Stakeholders. International Journal of Technology Assessment in Health Care, 41(1), Article e71. https://doi.org/10.1017/S0266462325100536

Grimm, S. E., van Mastrigt, G., & Hiligsmann, M. (2025). Advancing the economics of prevention: emerging methods and approaches. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2570689

Mugari, C., Lukwa, A. T., Okova, D., Chiwire, P., & Hiligsmann, M. (2025). Cost-effectiveness of HIV prevention interventions in sub-Saharan Africa (2019-2025): a systematic review. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2570695

Raskin, N., Hiligsmann, M., Rebutoc, A. R., Bansback, N., Boonen, A., Buchbinder, R., Falahee, M., Fraenkel, L., Marshall, D. A., Maxwell, L., Nieuwlaat, R., Proulx, L., Saadat, P., Shea, B., Tugwell, P., Wiercioch, W., Beaton, D., Richards, P., Schünemann, H., ... Hazlewood, G. S. (2025). Standardizing health outcomes for people with rheumatoid arthritis receiving disease modifying drug therapy: A rapid review of patient-decision aids and preference studies to inform the development of OMERACT Health Outcome Descriptors. Seminars in Arthritis and Rheumatism, 74, Article 152769. https://doi.org/10.1016/j.semarthrit.2025.152769

Sikking, M., Wiethoff, I., Henkens, M., Evers, S., Stroeks, S., Venner, M., Weerts, J., Brunner-la Rocca, H.-P., Knackstedt, C., van Empel, V., Michels, M., Heymans, S., Hiligsmann, M., & Verdonschot, J. (2025). High societal costs and reduced health-related quality of life in inflammatory and systemic immune disease-associated dilated cardiomyopathies. Quality of Life Research, 34(10), 2901-2910. https://doi.org/10.1007/s11136-025-04027-5

Fuggle, N., Rizzoli, R., Beaudart, C., Cortet, B., Curtis, E. M., Hiligsmann, M., Kaufman, J.-M., Veronese, N., Albergaria, B. H., Al-Daghri, N., Alokail, M., Brandi, M. L., Bruyère, O., Burlet, N., Campusano, C., Casado, E., Cavalier, E., Chandran, M., Cooper, C., ... Harvey, N. C. (2025). Parathyroid hormone receptor agonists in the management of osteoporosis. Nature reviews. Rheumatology, 21(10), 599-611. https://doi.org/10.1038/s41584-025-01287-w

Daccache, C., Hiligsmann, M., Evers, S. M. A. A., Rizk, R., & Karam, R. (2025). Barriers to and facilitators of implementing the Lebanese Health economic evaluation guideline: an initial exploration. Expert Review of Pharmacoeconomics & Outcomes Research. https://doi.org/10.1080/14737167.2025.2559092